SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019103
Filing Date
2016-05-11
Accepted
2016-05-11 16:11:28
Documents
47
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20160331.htm 10-Q 1521888
2 EX-31.1 life-ex311_9.htm EX-31.1 9558
3 EX-31.2 life-ex312_6.htm EX-31.2 9649
4 EX-32.1 life-ex321_10.htm EX-32.1 4992
5 EX-32.2 life-ex322_8.htm EX-32.2 4985
  Complete submission text file 0001564590-16-019103.txt   5869330

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT life-20160331.xml EX-101.INS 1487182
7 XBRL TAXONOMY EXTENSION SCHEMA life-20160331.xsd EX-101.SCH 35936
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20160331_cal.xml EX-101.CAL 39745
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20160331_def.xml EX-101.DEF 138623
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20160331_lab.xml EX-101.LAB 289361
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20160331_pre.xml EX-101.PRE 227316
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 161640010
SIC: 2836 Biological Products, (No Diagnostic Substances)